23andMe and motion sickness

被引：0

作者：

Jordan, Bertrand

机构：

[1] UMR 7268 ADÉS, Aix-Marseille, Université/EFS/CNRS, Espace éthique méditerranéen, Hôpital d'adultesla Timone, 264, rue Saint-Pierre, Marseille Cedex 05

[2] CoReBio PACA, Parc Scientifique de Luminy, Marseille Cedex 09

来源：

M S-MEDECINE SCIENCES | 2016年 / 32卷 / 05期

关键词：

SUSCEPTIBILITY;

D O I：

10.1051/medsci/20163205022

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

A Genome Wide Association Study on propensity to motion sickness published by 23andMe gives interesting results, shows validity for self-reported phenotypic information and underlines the value of the model developed by the company for customer participation in genetic studies.

引用

页码：518 / 521

页数：4

共 50 条

[21] 23andMe wades further into drug discovery
Petrone, Justin
[J]. NATURE BIOTECHNOLOGY, 2017, 35 (10) : 897 - 897
[22] The rise and fall and rise again of 23andMe
Erika Check Hayden
[J]. Nature, 2017, 550 : 174 - 177
[23] Bringing 23andMe Into the Human Genetics Classroom
Smith, Emmett
[J]. FASEB JOURNAL, 2020, 34
[24] FDA approves 23andMe gene carrier test
不详
[J]. NATURE BIOTECHNOLOGY, 2015, 33 (05) : 435 - 435
[25] FDA approves 23andMe gene carrier test
[J]. Nature Biotechnology, 2015, 33 (5) : 435 - 435
[26] 23andMe genetic tests banned by US FDA
Bond, Theo
[J]. PHARMACOGENOMICS, 2014, 15 (02) : 129 - 129
[27] Algorithmic Abstraction and the Racial Neoliberal Rhetorics of 23andMe
Weisse, Kathleen Daly
Jung, Julie
Sharp-Hoskins, Kellie
[J]. RHETORIC REVIEW, 2021, 40 (03) : 284 - 299
[28] 23andMe disease risk tests OK'd
不详
[J]. SCIENCE, 2017, 356 (6334) : 116 - 116
[29] PHARMACEUTICALS GSK, 23andMe to apply genetics to drug discovery
Cross, Ryan
[J]. CHEMICAL & ENGINEERING NEWS, 2018, 96 (31) : 14 - 14
[30] Silver Spring, Maryland 4 FDA Reins in 23andMe
不详
[J]. SCIENCE, 2013, 342 (6163) : 1152 - 1153

← 1 2 3 4 5 →